Home › Funds › GordonMD Global Investments LP › TSHA

GordonMD Global Investments LP position in TSHA

TAYSHA GENE THERAPIES INC · Health Care

GordonMD Global Investments LP reported holding 248,000 shares of TSHA (TAYSHA GENE THERAPIES INC) in its Q3 2026 13F filing — a position valued at US$6.2M, representing 3.72% of its reported portfolio and ranking #12 among its reported holdings. GordonMD Global Investments LP has disclosed TSHA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)248.00K sh
Reported value held$6.19M
Portfolio Weight3.72%
First reportedQ4 2025
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How GordonMD Global Investments LP's TSHA position evolved

GordonMD Global Investments LP first disclosed a stake in TSHA in Q4 2025 at 1,330,901 shares (US$7.3M). The position peaked in Q2 2026 at 723,185 shares, worth US$24.5M. Across 4 filings, GordonMD Global Investments LP increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 248,000 shares valued at US$6.2M — a reduction of -475,185 shares quarter over quarter.. Notable position changes include a 45% trim in Q1 2026 (shares rose 52% over the following quarter), a 66% trim in Q3 2026 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.33M $7.32M New
Q1 2026 737.55K $22.22M Reduce
Q2 2026 723.18K $24.50M Reduce
Q3 2026 248.00K $6.19M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TSHA and 13F data

TSHA (TAYSHA GENE THERAPIES INC) is a Health Care company. 47 other funds we track also report a position in TSHA — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$160.4M), Vestal Point Capital, LP (US$132.2M), Avoro Capital Advisors LLC (US$116.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TSHA

All TSHA fund holders →

FAQ

How long has GordonMD Global Investments LP held TSHA?

GordonMD Global Investments LP has disclosed TSHA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is GordonMD Global Investments LP's current position in TSHA?

As of Q3 2026, GordonMD Global Investments LP holds 248.00K shares of TSHA (TAYSHA GENE THERAPIES INC), valued at $6.19M, representing 3.72% of its reported portfolio and ranking #12.

Has GordonMD Global Investments LP been buying or selling TSHA?

In the latest 13F filing (Q3 2026), GordonMD Global Investments LP reduced its position in TSHA. The position peaked in Q2 2026 at 723.18K shares.

Which other funds hold TSHA?

Other major institutional holders of TSHA include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Avoro Capital Advisors LLC, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.